Pharmacology Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Pharmacology Trials in Brazil

Pharmacology Trials in Brazil – CRO Partner

Pharmacology trials are pivotal in assessing the safety and effectiveness of new drugs and treatments before they reach the market. Brazil, with its large and diverse population, robust research infrastructure, and thriving pharmaceutical industry, has emerged as a key player in the field of clinical research.

In this blog, we will delve into the landscape of pharmacology trials in Brazil, exploring the advancements made, the opportunities available, and the impact these trials have on healthcare innovation.

Advancements in Pharmacology Trials in Brazil

Brazil has made significant advancements in the field of pharmacology trials, establishing itself as a prominent hub for clinical research. The country’s extensive network of research institutions, renowned academic centers, and well-trained investigators contribute to the high-quality execution of trials.

Brazil’s diverse population, comprising various ethnicities and genetic backgrounds, enables more comprehensive assessments of drug responses and supports personalized medicine approaches.

One notable advancement in Brazil’s pharmacology trials is the focus on tropical diseases. With its vast tropical regions, Brazil serves as an ideal location for studying diseases such as dengue, malaria, and Chagas disease. This research not only benefits the local population but also has global implications, as these diseases affect millions of people worldwide.

Brazilian research centers and pharmaceutical companies actively collaborate with international partners, attracting multinational clinical trials to the country. This collaboration fosters knowledge exchange, promotes the adoption of cutting-edge trial methodologies, and enhances Brazil’s scientific capabilities.

Pharmacology Trials in Brazil

Pharmacology Trials in Brazil

Pharmacology Trials in Brazil

Opportunities and Challenges in Pharmacology Trials in Brazil

Brazil offers numerous opportunities for pharmacology trials. Its diverse population, spanning different age groups and socio-economic backgrounds, allows for comprehensive evaluations of drug safety and efficacy. The country’s large patient pool and well-established healthcare infrastructure facilitate recruitment and provide a broad range of participants for clinical trials.

Furthermore, Brazil has made significant strides in streamlining its regulatory processes for clinical trials. The National Health Surveillance Agency (ANVISA) plays a vital role in ensuring ethical standards, patient safety, and timely approvals. The simplified regulatory framework and expedited approval processes have made Brazil an attractive destination for conducting pharmacology trials.

However, challenges persist. Brazil faces the need for enhanced regulatory harmonization, as there can be inconsistencies and delays in trial approvals across different regions. Addressing these issues would further improve the efficiency and competitiveness of Brazil’s clinical research sector.

Another challenge is the adequate training and availability of qualified clinical research professionals. Investing in educational programs and professional development opportunities for investigators and research staff can help bridge this gap and ensure the successful implementation of pharmacology trials.

Impact and Future Outlook

Pharmacology trials in Brazil have a significant impact on healthcare innovation, benefiting both the local population and the global scientific community. By participating in clinical trials, Brazilians gain access to cutting-edge treatments and therapies before they become widely available. This not only improves healthcare outcomes but also contributes to the country’s overall healthcare advancement.

Furthermore, conducting pharmacology trials in Brazil attracts investments, stimulates economic growth, and creates job opportunities within the clinical research sector. The presence of international pharmaceutical companies and research organizations fosters knowledge transfer and collaboration, contributing to scientific advancements in Brazil.

Looking ahead, Brazil should continue to prioritize the development of a robust regulatory environment that promotes harmonization and efficiency. Strengthening partnerships between academia, industry, and government bodies will foster a collaborative ecosystem for clinical research. Investing in training programs and professional development will ensure a skilled workforce capable of conducting high-quality pharmacology trials.


Brazil’s advancements in pharmacology trials, coupled with its diverse population and robust research infrastructure, have positioned the country as a key player in the global clinical research landscape. By addressing challenges, fostering collaboration, and investing in regulatory efficiency and training programs, Brazil can further enhance its role in pharmacology trials, benefiting its population and contributing to healthcare innovation on a global scale.


Pharmacology Trials in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Pharmacology Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Pharmacology Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Pharmacology Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Pharmacology Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Pharmacology Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Pharmacology Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Pharmacology Trials in Brazil

The Cohortias Team

Pharmacology Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Pharmacology Trials in Brazil

Network & Partnerships